Status:
COMPLETED
Alvimopan and Ileus in PSF
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Orthopedic Research and Education Foundation
Barnes-Jewish Hospital
Conditions:
Ileus
Spinal Fusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to determine with Alvimopan reduces the incidence of post operative ileus in patients who undergo posterior spinal fusion.
Detailed Description
Posterior spinal fusion (PSF) is a common orthopaedic procedure associated with a high incidence of post-operative ileus (POI) and concomitant increased length of hospital stay (LOHS). POI is exacerba...
Eligibility Criteria
Inclusion
- adult patients undergoing elective PSF of at least 5 levels and/or fixation to pelvis
Exclusion
- pregnant women
- ischemic heart disease
- chronic liver or renal disease
- prior bowel resection
- presence of colostomy or ileostomy
- gastroparesis
- complete bowel obstruction
- inflammatory bowel disease (ulcerative colitis or Crohn's disease).
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT02218190
Start Date
August 1 2014
End Date
January 1 2019
Last Update
May 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barnes Jewish Hospital / Washington University in St. Louis School of Medicine
St Louis, Missouri, United States, 63108